Diet, Health and Disease
Background
Under-nutrition impairs the immune system, suppressing immune functions that are fundamental to the efficient protection of the host from bacterial and viral infections. This relationship applies not only to nutritionally deprived children in developing countries but also to people of all ages throughout the world. For example, adverse effects on immune function may be present in people with micronutrient deficiencies or nutritional imbalances. Adverse effects on immune function may also be present in some instances of “over-nutrition”, such as obesity or high intakes of total fat or certain types of fatty acids. Moreover, the diet may have positive effects on the immune system. A major focus of current research is to examine the possibility of improving the function of the immune system of healthy people by nutritional means with the aim of improving health.
Objectives
The task force focuses on markers of immune functions that are relevant to health and well-being. The objective of the task force is to improve the understanding of how nutrients can improve the immune system in healthy people, and to put together evidence for the validation of selected markers.
Impact
The work of the task force will provide insight into the mechanisms whereby nutrition influences immune status, with potential implications for health claims.
In 2009 the task force commissioned an extensive review of the molecular and cellular processes underlying distinct chronic inflammatory conditions. It summarises the evidence for the impact of dietary components such as long chain omega-3 fatty acids, antioxidant vitamins, plant flavonoids, prebiotics and probiotics on these inflammatory processes (‘Inflammatory Disease Processes and Interactions with Nutrition’ British Journal of Nutrition 2009; 101(Suppl.1):S1-S45).
Another review commissioned by the task force summarises the immune function assays commonly used as markers in human intervention studies and evaluates their biological relevance (‘Markers to Measure Immunomodulation in Human Nutrition Intervention Studies’, British Journal of Nutrition 2005;94(3):452-481). The aim of the review was to define a set of relevant markers of immune functions that can be used to scientifically substantiate an improved resistance against infections. A range of in vivo, ex vivo and in vitro measures is explained and scored for their suitability to assess dietary modulation of immune function. The paper concludes that combining clinical endpoints with a set of markers with high and medium suitability is the best approach to measure immunomodulation in human nutrition intervention studies.
The task force has recently updated the Concise Monograph on Nutrition and Immunity in Man. The new edition has a special focus on the effect of nutrition on the reduction of disease risk, including information about the effect of pre- and probiotics, fatty acids and vitamins on the immune system. The updated Concise Monograph will be widely distributed to scientists, health professionals, general practitioners, students and other interested parties.
Activities
Markers of Inflammation
This activity aims to evaluate markers of inflammation for their suitability. Today, clear recommendations on which markers of inflammation to use and how to interpret changes/patterns are missing. The heterogeneity of the tools used to assess the relationship between clinical symptoms and the biomarkers of inflammation is a significant limiting factor for the progress of knowledge on the impact of nutrition on chronic inflammatory responses. In particular, the task force would like to gain a better insight into good predictive markers of chronic inflammation. Ultimately, the activity could produce recommendations on markers to include in future studies and/or novel markers to develop/validate.
An expert group is developing a preliminary list of key biomarkers of inflammation, covering a selection of endpoints and life stages. A workshop will be organised in order to review and validate the markers with a broader audience. This activity will result in a peer-reviewed publication.
Workshop on Biomarkers of Inflammation - Towards guidance for future nutrition studies
The aim of the workshop to be held on 14-15 May 2012 in Sevilla (ES) is to review and comment on the draft manuscript that has been prepared by the expert group, to help validate the conclusions presented in the manuscript. The main objective of the workshop is to review the experts’ work in listing biomarkers of inflammation and identifying emerging concepts in this area. By this approach, the workshop contributes to a better understanding of the current limitations and emerging opportunities for assessing inflammation. The goal of the workshop is to identify robust markers of inflammation and provide guidance to future studies assessing inflammation during nutritional studies in the general population.
Markers of Immuno-modulation for the General Population
It is known that immune markers are modulated within a certain range where it is still considered as safe. The lower and upper limits of this safe range are known for most of the immune markers from medical data. What is not always known is ‘how a certain ingredient can trigger a modulation’ and ‘how detrimental/beneficial this stimulation can be on the consumer’s health’. The Nutrition and Immunity Task Force together with the Probiotics Task Force commissioned an expert group to provide relevant markers and reference values in context of immuno-modulation induced by a dietary intervention within the healthy population.
A workshop will be held on 16 and 17 April 2012 with the objectives firstly to invite external experts to review the work done by the group. Secondly, it is aimed to propose scenarios for interpreting results observed during a trial. By this approach, the workshop contributes to a better understanding of the current limitations and insight in emerging opportunities for assessing immune modulation. It will thus promote further consensus on valuable and accessible markers for conducting intervention trials.
The outcome will be submitted to a peer-reviewed journal. The publication will summarise the markers reflecting normal function of the immune system which are indicative for immune modulation by nutrients/bio-active ingredients. It will also include proposals for interpreting variations in these markers.
Further information is also provided under the section on the transversal activity - Marker Validation Initiative ‘Step 1’.
Update of the Concise Monograph ‘Nutrition and Immunity in Man’
The task force agreed to update the ILSI Europe Concise Monograph ‘Nutrition and Immunity in Man’ that was first published in 1999. Scientific knowledge on the complex network of specialised cells and organs that make up our immune system, as well as the impact of nutritional factors on these protection mechanisms, has considerably improved over the past years. The purpose of the update is to include relevant new information on pro- and prebiotics, fatty acids and vitamins. New insights are included in particular with regard to reduction of disease risk. A new section will also be added on functional foods and health claims related to the immune system.
2012 – The Year Ahead
The task force organised a brainstorming meeting to identify potential new activities. Several potential activities were identified such as:
- To give practical guidance on how response to vaccination can be used as a marker for immune function (Which vaccines?, Which populations?, Suboptimal vs optimal schedules?, Suboptimal vs optimal immune status?);
- To do a literature review on the role of epigenetics on immuno-modulation and how it is influenced by nutrition;
- To examine how we can address immune maintenance in health beyond elderly. How to address (define, quantify) health maintenance through immune in vivo and ex vivo challenges.
Task Force Collaborators
Members 2012
Dr. Raphaëlle Bourdet-Sicard - Chair |
Danone |
FR |
Dr. Willem Vas Dias - Co-Chair - |
Merck |
UK |
| |
|
|
Dr. Jalil Benyacoub |
Nestlé |
CH |
Dr. Murielle Cazaubiel |
Institut Mérieux |
FR |
| Dr. Judith Moreines |
Pfizer Consumer Healthcare |
US |
Dr. André Siemensma |
Royal FrieslandCampina |
NL |
Dr. Danielle Wolvers |
Unilever |
NL |
Dr. Jia Zhao |
Yakult Europe |
NL |
| |
|
|
Ms. Marie Latulippe |
ILSI Europe |
BE |
| Dr. Stéphane Vidry |
ILSI Europe |
BE |
Ms. Ria Dewit |
ILSI Europe |
BE |
Expert Group on Markers of Inflammation
Prof. Philip Calder - Chair - |
University of Southampton |
UK |
| |
|
|
Dr. Namanjeet Ahluwalia |
Université de Paris – INSERM |
FR |
Dr. Ruud Albers |
Consultant |
NL |
Dr. Nabil Bosco |
Nestlé |
CH |
Dr. Raphaëlle Bourdet-Sicard |
Danone |
FR |
Prof. Dirk Haller |
Technical University of Munich |
DE |
Prof. Stephen Holgate |
University of Southampton |
UK |
Prof. Ascención Marcos Sánchez |
Spanish National Research Council |
ES |
| Dr. Judith Moreines |
Pfizer Consumer Healthcare |
US |
Dr. Christine M’Rini |
Institut Mérieux |
FR |
Prof. Michael Müller |
Wageningen University |
NL |
Prof. Graham Pawelec |
University of Tubingen |
DE |
Dr. Joost van Neerven |
Royal FrieslandCampina |
NL |
Prof. Bernhard Watzl |
Max Rubner-Institute (MRI) |
DE |
Dr. Jia Zhao |
Yakult Europe |
NL |
| |
|
|
| Ms. Marie Latulippe |
ILSI Europe |
BE |
Dr. Stéphane Vidry |
ILSI Europe |
BE |
Workshop on Biomarkers of Inflammation - Towards guidance for future nutrition studies
Organising committee |
|
|
Prof. Philip Calder - Chair - |
University of Southampton |
UK |
|
|
|
Dr. Namanjeet Ahluwalia |
Université de Paris – INSERM |
FR |
Dr. Ruud Albers |
Consultant |
NL |
Dr. Nabil Bosco |
Nestlé |
CH |
Dr. Raphaëlle Bourdet-Sicard |
Danone |
FR |
|
|
|
Ms. Marie Latulippe |
ILSI Europe |
BE |
Dr. Stéphane Vidry |
ILSI Europe |
BE |
Expert Group on Markers of Immuno-modulation for the General Population
Prof. Ulrich Sack - Chair - |
University of Leipzig |
DE |
Dr. Phoukham Phothirath - Co-Chair- |
Nestlé |
CH |
| |
|
|
Dr. Ruud Albers |
Consultant |
NL |
Dr. Raphaëlle Bourdet-Sicard |
Danone |
FR |
Prof. Philip Calder |
University of Southampton |
UK |
Dr. Murielle Cazaubiel |
Biofortis |
FR |
Dr. Udo Herz |
Mead Johnson Nutrition |
NL |
Dr. Claude Lambert |
Centre Hospitalier Universitaire Saint-Etienne |
FR |
Dr. Irene Lenoir-Wijnkoop |
IDF - ILSI Liaison Officer |
FR |
Prof. Jean-François Nicolas |
Centre Hospitalier Universitaire Lyon-Sud |
FR |
Dr. Arthur Ouwehand |
Danisco |
FI |
Dr. Tomoyoki Sako |
Yakult Europe |
NL |
Prof. Seppo Salminen |
University of Turku |
FI |
Dr. André Siemensma |
Royal FrieslandCampina |
NL |
Prof. Henk van Loveren |
National Institute of Public Health and the Environment – RIVM |
NL |
| |
|
|
Ms. Agnès Méheust |
ILSI Europe |
BE |
| Ms. Marie Latulippe |
ILSI Europe |
BE |
Concise Monograph on Nutrition and Immunity - Update
Author |
|
|
Dr. Sandra Gredel |
Independent scientific writer |
DE |
Scientific Editor |
|
|
Prof. Bernhard Watzl |
Max Rubner-Institut (MRI) |
DE |
Task Force Coordinator |
|
|
Dr. Willem Vas Dias |
Seven Seas |
UK |
Publication Committee Coordinator |
|
Dr. Corinne Herouet–Guicheney |
Bayer SAS |
FR |
Series Editor |
|
|
Mr. John Howlett |
Consultant |
UK |
ILSI Europe Coordinators |
|
|
Dr. Lena Jönsson |
ILSI Europe |
BE |
Publications
S. Gredel. Nutrition and Immunity in Man - Second Edition. ILSI Europe Concise Monograph Series 2011: 1-32.
P. Calder, R. Albers, J-M. Antoine et al. Inflammatory Disease Processes and Interactions with Nutrition. British Journal of Nutrition 2009; 101(Suppl.1):S1-S45.
R. Albers, J-M Antoine, R. Bourdet-Sicard et al. Markers to Measure Immunomodulation in Human Nutrition Intervention Studies. British Journal of Nutrition 2005;94(3):452-481.